(Iso-)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer

被引：3
|
作者：
Boesch, Maximilian [1 ,2 ,3 ,4 ]
Reimer, Daniel [5 ]
Sopper, Sieghart [2 ,4 ]
Wolf, Dominik [2 ,6 ]
Zeimet, Alain G. [5 ]
机构：
[1] Kantonsspital St Gallen, Inst Immunobiol, Rorschacherstr 95, CH-9007 St Gallen, Switzerland
[2] Med Univ Innsbruck, Internal Med 5, Innsbruck, Austria
[3] Oncotyrol Ctr Personalized Canc Med GmbH, Innsbruck, Austria
[4] Tyrolean Canc Res Inst TKFI, Innsbruck, Austria
[5] Med Univ Innsbruck, Dept Gynecol & Obstet, Anichstr 35, A-6020 Innsbruck, Austria
[6] Univ Clin Bonn UKB, Med Clin 3, Bonn, Germany
来源：
ONCOLOGIST | 2018年 / 23卷 / 07期
基金：
奥地利科学基金会;
关键词：
Vav3; Guanine nucleotide exchange factor; Cancer stem cell; Transcript variant; Protein isoform; NUCLEOTIDE EXCHANGE FACTORS; CELLS; ANGIOGENESIS; SURVIVAL; FAMILY;
D O I：
10.1634/theoncologist.2017-0683
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：757 / 759
页数：3
相关论文
共 50 条
  • [21] Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer
    Lee, Kiwon
    Liu, Yin
    Mo, Jun Qin
    Zhang, Jinsong
    Dong, Zhongyun
    Lu, Shan
    BMC CANCER, 2008, 8 (1)
  • [22] Vav3 oncogene regulates androgen receptor activity and is involved in cell growth in human prostate cancer
    Dong, Zhongyun
    Liu, Yin
    Lee, Juwon
    Lu, Shan
    Wang, Amy
    Wang, Lu-Hui
    Revelo, Monica
    Lu, Shan
    CANCER RESEARCH, 2006, 66 (08)
  • [23] Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer
    Dong, Zhongyun
    Liu, Yin
    Levin, Linda
    Oleksowicz, Leslie
    Wang, Jiang
    Lu, Shan
    ONCOLOGY REPORTS, 2011, 25 (06) : 1511 - 1516
  • [24] Targeted overexpression of Vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer.
    Liu, Yin
    Mo, Jun Qin
    Hu, Qiande
    Boivin, Gregory
    Levin, Linda
    Lu, Shan
    Yang, Dianer
    Dong, Zhongyun
    Lu, Shan
    CANCER RESEARCH, 2009, 69
  • [25] Loss of VAV3 expression as a novel biomarker and indicator of chemosensitivity in basal-like breast cancer
    Getz, Julie E.
    Anderson, Eric M.
    Black, Michael A.
    Hedenfalk, Ingrid A.
    Balagurunathan, Yoganand
    Willis, Amanda L.
    Mancini, Catherine M.
    Ramos, Pilar
    Cunliffe, Heather E.
    CANCER RESEARCH, 2010, 70
  • [26] A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer
    Rao, S.
    Lyons, L. S.
    Fahrenholtz, C. D.
    Wu, F.
    Farooq, A.
    Balkan, W.
    Burnstein, K. L.
    ONCOGENE, 2012, 31 (06) : 716 - 727
  • [27] Investigating VAV3 Expression as a Novel Biomarker and Indicator of Chemosensitivity in Basal-Like Breast Cancer
    Getz, J. E.
    Anderson, E. M.
    Balagurunathan, Y.
    Black, M. A.
    Hedenfalk, I. A.
    Willis, A. L.
    Ramos, P.
    Mancini, C. M.
    Cunliffe, H. E.
    CANCER RESEARCH, 2010, 70
  • [28] Loss of VAV3 expression as a novel biomarker and indicator of chemosensitivity in basal-like breast cancer
    Getz, Julie E.
    Anderson, Eric M.
    Black, Michael A.
    Hedenfalk, Ingrid A.
    Balagurunathan, Yoganand
    Willis, Amanda L.
    Mancini, Catherine M.
    Ramos, Pilar
    Cunliffe, Heather E.
    CANCER RESEARCH, 2010, 70
  • [29] Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer
    Kiwon Lee
    Yin Liu
    Jun Qin Mo
    Jinsong Zhang
    Zhongyun Dong
    Shan Lu
    BMC Cancer, 8
  • [30] Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells
    Tsuboi, Makiko
    Taniuchi, Keisuke
    Furihata, Mutsuo
    Naganuma, Seiji
    Kimura, Masashi
    Watanabe, Ryohei
    Shimizu, Takahiro
    Saito, Motoaki
    Dabanaka, Ken
    Hanazaki, Kazuhiro
    Saibara, Toshiji
    PANCREATOLOGY, 2016, 16 (05) : 905 - 916
12345